Siberian State Medical University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Tomsk Russian Federation (1888)

Organization Overview

First Clinical Trial
2019
NCT03855046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Siberian State Medical University

Active Ingredients

Drugs in Phase 4 Trials (1)

incobotulinumtoxinA (Xeomin) (1 trial)

Drugs in Phase 2 Trials (1)

nitric oxide (inomax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Fissure in Ano (Phase 4)

Hypoxia (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2